Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Current Deferred Revenue (2019 - 2022)

Historic Current Deferred Revenue for Aethlon Medical (AEMD) over the last 4 years, with Q4 2022 value amounting to $574245.0.

  • Aethlon Medical's Current Deferred Revenue rose 15000.0% to $574245.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $574245.0, marking a year-over-year increase of 15000.0%. This contributed to the annual value of $344547.0 for FY2022, which is 20000.0% up from last year.
  • Latest data reveals that Aethlon Medical reported Current Deferred Revenue of $574245.0 as of Q4 2022, which was up 15000.0% from $574245.0 recorded in Q3 2022.
  • In the past 5 years, Aethlon Medical's Current Deferred Revenue registered a high of $574245.0 during Q3 2022, and its lowest value of $100000.0 during Q3 2019.
  • Moreover, its 4-year median value for Current Deferred Revenue was $229698.0 (2021), whereas its average is $280033.0.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first skyrocketed by 40702.2% in 2020, then plummeted by 7734.83% in 2021.
  • Quarter analysis of 4 years shows Aethlon Medical's Current Deferred Revenue stood at $100000.0 in 2019, then soared by 407.02% to $507022.0 in 2020, then crashed by 54.7% to $229698.0 in 2021, then skyrocketed by 150.0% to $574245.0 in 2022.
  • Its last three reported values are $574245.0 in Q4 2022, $574245.0 for Q3 2022, and $459396.0 during Q2 2022.